UPDATE 1-GlaxoSmithKline breathes easier as U.S. approves triple lung drug

* CEO sees it as one of three "critical" new drug launches (Adds detail on competition, analyst reaction, shares)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.